News & Media

We are excited to announce that Glenn Bronkers, our Chief Technical Officer, has been invited to present at the International Coronary Congress, organized by the International Society for Coronary Artery Surgery (#ISCAS), in London on Sunday, December 12th. Glenn will share valuable insights on ELANA Anastomotic Connectors...

Dec 2024

Glenn Bronkers Presenting at International Coronary Congress

Article by st. Antonius Ziekenhuis 'Heart surgeon Bart van Putte, working from the St. Antonius Heart Center as the lead researcher, is conducting a study to demonstrate that the connection between two blood vessels no longer needs to be stitched. Instead, the new blood vessel is attached to the coronary...

Sep 2024

Unique in the World: Coronary Artery Bypasses Without Stitches

Het Financieele Dagblad recently featured AMT Medical, providing an in-depth look at our journey, the challenges we've successfully navigated, and the significant potential we hold in revolutionizing the healthcare market. The article not only underscores the impact of our innovative heart bypass technology but also highlights he relentless dedication and ingenuity of our team..

Aug 2024

Mentioned on Het Financeele Dagblad

The market introduction of AMT Medical’s Elana Heart Bypass System is well on track. We successfully operated on the first ten patients in Phase I of the SAFE-CAB trial, establishing the safety and feasibility of our Elana Heart Bypass System. The larger Phase II, with 75 enrolled patients, has now started. In addition, final discussions with the U.S. Food & Drug Administration (FDA) have now started to commence the Early Feasibility Trial in the U.S...

Sep 2023

News from AMT Medical

AMT Medical announces today that the company is beginning Phase II of the SAFE-CAB Trial to obtain CE (Conformité Européene) mark of the Elana Heart Bypass System in Europe. Furthermore, final discussions with the U.S. Food & Drug Administration (FDA) have now started to commence....

Sep 2023

Press Release – AMT Medical on Track to Hit Next Milestones

It is with great pleasure to announce that AMT Medical has achieved yet another milestone in our quest for excellence. We were thrilled to receive the coveted EN ISO 13485:2016 certificate, proving our unwavering commitment to quality and customer satisfaction.

May 2023

AMT Medical B.V. achieved EN ISO 13485:2016 certification

We proudly announce that our ELANA project is supported by a multimillion euro grant of the European Union within the European Innovation Council Accelerator grant. Besides the international recognition and significant financial support, we are proud to work on our...

Jan 2023

European Innovation Council Accelerator

We are standing on the threshold of another exciting year for AMT medical. In 2022 we successfully operated on ten heart patients, proving the safety and feasibility of our ELANA Heart Bypass Solution. After years of climbing, this feels like being on the top of the mountain overlooking the world. In 2023 we...

Jan 2023

Newsletter #7

At the 36th EACTS Annual Meeting we proudly presented the very positive results of the first-in-human (FIH) trials for the innovative ELANA Heart Bypass Solution. These trial results represent positive news for both surgeons - and their patients. We’re changing the world of heart bypass surgery.

Nov 2022

Newsletter #6

Milan (Italy), October 8, 2022- The preliminary results of the first-in-human (FIH) trials for the innovative ELANA Heart Bypass Solution have been unveiled today and look promising. At the 36th EACTS Annual Meeting Late Breaking Trials session, Drs. Patrick Klein, cardiothoracic surgeon the St. Antonius Hospital, Nieuwegein, The Netherlands, and...

Oct 2022

Press Release

In the latest newsletter we proudly shared the news of successfully operating on the first ten patients with the ELANA® HEART technology in a study context. We still feel quite overwhelmed by reaching this milestone, but already have other exciting news to share. Our long-cherished dream is becoming more real every day!

Sep 2022

Newsletter #5

This spring we took an important next step in our journey to banish open heart surgery from the world, improving the lives of 1 million people who need a bypass each year. After years of preparation, we operated the first ten patients. A huge step on our road to an enormous breakthrough in heart surgery!

Jul 2022

Newsletter #4

Enthusiastic responses and a growing anticipation of how our breakthrough technology will change the future world of bypass-surgery. This is what was achieved at the 70th ESCVS congress that took place from 20 to 23 June in Liège. ELANA HEART technology took the stage during a mini symposium with presentations of two primary researchers , Dr. Patrick Klein, cardiothoracic surgeon and prof. dr. Stephan Jacobs, cardiothoracic and vascular surgeon.

Jun 2022

State of the art of sutureless coronary anastomoses

AMT medical has a new clean room on the innovative campus at the Zonneoord in Ede. This was finished by interflow

May 2022

New cleanroom

The AMT Medical Team wishes you and all the people you cherish a healthy and happy new year. In 2022, we are eager to continue working together on our dream: banishing open heart bypass surgery from the world!

Dec 2021

Newsletter #3

A little bit of covid-related delay, but still on track!

May 2021

Newletter #2

We are proud to announce that our paper about the 6 months follow-up research to the ELANA Heart Bypass (Trinity-V2-prototype) is published by Innovations.

Mar 2021

Publication in Innovations

Read more about AMT Medical in the the interview of Rutger Tulleken, CEO of AMT Medical and Getlin Visser, CSO, by our collaboration partner Catalyze.

Jan 2021

Interview by Catalyze

The AMT Medical Team wishes you and all the people you cherish a healthy and happy new year. In 2021, we are eager to continue working together on our dream: banishing open heart bypass surgery from the world!

Dec 2020

Newsletter #1

During the Covid-19 crisis, AMT Medical secures € 10 million of financing. Funding will be used to bring the ELANA™ Heart Bypass system to the market. During the Covid-19 period, AMT Medical has gained trust in the ELANA innovation from a regional development fund Oost NL. Existing shareholders NextGen Ventures and Utrecht Holdings (UU/UMCU) are also financing this round. In total, AMT Medical has secured more than €10 million series A and non-dilutive funding...

Sep 2020

Press Release

Together with the St Antonius Hospital in Nieuwegein (Dr. B.P. (Bart) van PutteBart and Drs. P. (Patrick) Klein) and the UMC Utrecht (prof. dr. PAFM (Pieter A.) we are making big steps with our EFRO (“Operationeel Kansen voor West II”) grants. This gives us great help in the development of our unique technology with ELANA Heart Bypass to improve and simplify heart bypass operations. By improving bypass surgery with ELANA Heart Bypass, patients with coronary...

Aug 2020

EFRO Grant

First loan from Gelderland (a province of the Netherlands) innovation fund for medium-sized company. Innovation from AMT Medical improves the world of open heart surgery

Jul 2021

First loan ION+ to AMT Medical

Jul 2020

Article “patient saved” in dutch newspaper De Telegraaf (in Dutch)

We proudly announce that our KARDIO project is supported by a multimillion euro grant of “Operationeel Kansen voor West II” within the EFRO 2014-2020 program (Horizon 2020).

Mar 2019

KARDIO project

Jan 2019

Article from the Economic Board of Utrecht (in Dutch)

Start collaboration with Prof. Dr. Volkmar Falk and Dr. Stephan Jacobs to prove our technique in the first patients.

Aug 2018

Collaboration Deutsches Herzzentrum Berlin

Our ELANA heart (TECAB) project is ranked number 5 out of hundreds of European Grant applications (1 is the highest). Innovative companies from all markets and from over 35 countries could apply and were judged by an independent European expert committee who considered our project to be a “paradigm shifting innovation”. Next to the international recognition and significant financial support, we are proud to work together with our consortium member...

Jul 2018

Europe: “A paradigm shifting innovation”

Start collaboration with Dr. Bart van Putte. His first PhD started at our Labs in september 2018.

Apr 2018

Collaboration St Antonius Nieuwegein

After a succesfull pre-clinical study with 70 subjects, product optimilizations where made

Mar 2018

Succesful finished study

Together with Xeltis in Eindhoven we receive the MIT grant/subsidy.

Feb 2018

MIT Subsidy assigned

Philips buys Spectranetics, our partner in Catheter and Laser production. Since this take-over by Philips, they visit us on a regular basis to investigate collaboration.

Aug 2017

Philips buys our supplier

Investment from NextGen Ventures (part of Noaber foundation) and Utrecht Holdings (part of UMCU and UU in Utrecht).

Jun 2017

Capital Raise

Dec 2024

Sep 2024

Aug 2024

Sep 2023

Sep 2023

May 2023

Jan 2023

Jan 2023

Nov 2022

Oct 2022

Sep 2022

Jul 2022

Jun 2022

May 2022

Dec 2021

May 2021

Mar 2021

Jan 2021

Dec 2020

Sep 2020

Aug 2020

Jul 2021

Jul 2020

Mar 2019

Jan 2019

Aug 2018

Jul 2018

Apr 2018

Mar 2018

Feb 2018

Aug 2017

Jun 2017

Contact us today